Rapid Micro sees Q4 and FY 2021 revenue below consensus; provides 2022 outlook

seekingalpha2022-01-10

Rapid Micro Biosystems(NASDAQ:RPID)announces preliminary Q4 and FY 2021 revenue, and commercial revenue outlook for FY 2022.The Company currently expects total revenue of between $4.7M and $5.2M in Q4...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
1